Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification and validation of immunogenic potential of India specific HPV-16 variant constructs: In-silico &in-vivo insight to vaccine development.

Scientific reports - 28 Oct 2015

Kumar Anoop, Hussain Showket, Sharma Gagan, Mehrotra Ravi, Gissmann Lutz, Das Bhudev C, Bharadwaj Mausumi

Abstract excerpt

Cervical cancer is one of the most common gynecological cancers in the world but in India, it is the top most cancer among women. Persistent infection with high-risk human papillomaviruses (HR-HPVs) is the most important risk factor. The sequence variation(s) in the most common HR-HPV i.e. HPV type 16 leads to altered biological functions with possible clinical significance in the different geographical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibody Formation
Share to Computer Simulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Human papillomavirus 16

Share to Mice, Inbred BALB C

Share to Papillomavirus Infections

Share to Uterine Cervical Neoplasms

Share to Vaccines, DNA

Source

Open in PubMed Open full text

Identifiers

PMID: 26507515
DOI: 10.1038/srep15751
PMCID: PMC4623767

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification and validation of immunogenic potential of India specific HPV-16 variant constructs: In-silico &in-vivo insight to vaccine development.PMID 26507515Read ↗

Molecular variants of HPV-16 associated with cervical cancer in Indian population.Semantic proximity Read ↗

HPV16 L1 diversity and its potential impact on the vaccination-induced immunity.Semantic proximity Read ↗

Characterization of major capsid protein (L1) variants of Human papillomavirus type 16 by cervical neoplastic status in Indian women: Phylogenetic and functional analysis.Semantic proximity Read ↗

Worldwide genetic variations in high-risk human papillomaviruses capsid L1 gene and their impact on vaccine efficiency.Semantic proximity Read ↗

Design of a multi-epitope vaccine against cervical cancer using immunoinformatics approachesSemantic proximity Read ↗

HPV genotype prevalence in Indian women with cervical disease and estimation of the potential impact of HPV vaccines on prevention of cervical cancer.Semantic proximity Read ↗

L1 Gene Molecular Variation of Human Papilloma Virus Type 16 from Cervical Cancer PatientSemantic proximity Read ↗

In silico/In vivo analysis of high-risk papillomavirus L1 and L2 conserved sequences for development of cross-subtype prophylactic vaccineSemantic proximity Read ↗

Designing and immunomolecular analysis of a new broad-spectrum multiepitope vaccine against divergent human papillomavirus typesSemantic proximity Read ↗

Mutation Profile of HPV16 L1 and L2 Genes in Different Geographic Areas.Semantic proximity Read ↗

Identification of epitopes in Indian human papilloma virus 16 E6: A bioinformatics approachSemantic proximity Read ↗

Human papillomavirus genotype distribution in cervical cancer in India: results from a multi-center study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.